Summary
Regan Sparks, from Essex, England, uses a drug called Trikafta to manage her cystic fibrosis. The high cost of her medication has prevented her from getting a visa to work in Australia because it exceeds the healthcare cost limit set by the country. Despite her health improving and her desire to work abroad, the visa was denied because the medication costs more than allowed.
Key Facts
- Regan Sparks uses a drug called Trikafta for her cystic fibrosis.
- Cystic fibrosis is a genetic condition affecting the lungs and digestive system.
- Trikafta has greatly improved Regan’s health and quality of life.
- Australia limits the potential healthcare costs for visa applicants to A$86,000.
- Trikafta costs about A$250,000 a year, which is above this threshold.
- Regan’s visa application to work in Australia for a year was denied due to the cost of the medication.
- Regan has been able to travel to and enter other countries with her medication without issues.
